Home >  Term: Pediatric AIDS Clinical Trials Group 076 (PACTG 076)
Pediatric AIDS Clinical Trials Group 076 (PACTG 076)

A federally funded study that determined that the risk of mother-to-child transmission (MTCT) of HIV could be reduced by nearly 70% if the antiretroviral (ARV) drug zidovudine was given to a woman during pregnancy and labor and delivery and to the newborn. The Pediatric AIDS Clinical Trials Group 076 (PACTG 076) study contributed greatly to preventing MTCT of HIV.

0 0

Penulis

© 2024 CSOFT International, Ltd.